Persones / Equip Humà

F. Xavier Palomer Tarridas

Buscador de publicacions

Publicacions

  • Palomer FX, Pizarro J, Barroso E and Vazquez M.

    Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus.

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 29(3): 178-190. Nº de cites: 369

    [doi:10.1016/j.tem.2017.11.009]

  • Zarei M, Barroso E, Palomer FX, Dai J, Rada P, Quesada T, Escolà-Gil JC, Cedó L, Zali MR, Molaei M, Dabiri R, Vázquez S, Pujol E, Valverde ÁM, Villarroya-Gombau F, Liu Y, Wahli W and Vazquez M.

    Hepatic regulation of VLDL receptor by PPARß/d and FGF21 modulates non-alcoholic fatty liver disease.

    molecular metabolism . 8: 117-131. Nº de cites: 80

    [doi:10.1016/j.molmet.2017.12.008]

  • Botteri G, Montori M, Gumà A, Pizarro J, Cedó L, Escolà-Gil JC, Li D, Barroso E, Palomer FX, Kohan AB and Vazquez M.

    VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells.

    Diabetologia . 60(11): 2262-2273. Nº de cites: 29

    [doi:10.1007/s00125-017-4401-5]

  • Palomer FX, Barroso E, Zarei M, Botteri G and Vazquez M.

    PPAR beta/delta and lipid metabolism in the heart

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS . 1861(10): 1569-1578. Nº de cites: 39

    [doi:10.1016/j.bbalip.2016.01.019]

  • Garcia-Ramírez M, Hernández C, Palomer FX, Vazquez M and Simó R.

    Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-?B activity.

    ACTA DIABETOL . 53(1): 109-118. Nº de cites: 30

    [doi:10.1007/s00592-015-0759-3]

  • Palomer FX, Capdevila-Busquets E, Botteri G, Davidson MM, Rodríguez C, Martínez-González J, Vidal F, Barroso E, Chan TO, Feldman AM and Vazquez M.

    miR-146a targets Fos expression in human cardiac cells

    DISEASE MODELS & MECHANISMS . 8(9): 1081-1091. Nº de cites: 38

    [doi:10.1242/dmm.020768]

  • Salvadó L, Palomer FX, Barroso E and Vazquez M.

    Targeting endoplasmic reticulum stress in insulin resistance.

    TRENDS IN ENDOCRINOLOGY AND METABOLISM . 26(8): 438-448. Nº de cites: 172

    [doi:10.1016/j.tem.2015.05.007]

  • Barroso E, Rodríguez-Rodríguez R, Chacón MR, Maymó-Masip E, Ferrer L, Salvadó L, Salmerón E, Wabistch M, Palomer FX, Vendrell J, Wahli W and Vazquez M.

    PPARß/d ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1852(5): 1049-1058. Nº de cites: 19

    [doi:10.1016/j.bbadis.2015.02.010]

  • Chehaibi K, Cedó L, Metso J, Palomer FX, Santos D, Quesada H, Naceur Slimane M, Wahli W, Julve J, Vazquez M, Jauhiainen M, Blanco-Vaca F and Escolà-Gil JC.

    PPAR-ß/d activation promotes phospholipid transfer protein expression.

    BIOCHEMICAL PHARMACOLOGY . 94(2): 101-108. Nº de cites: 23

    [doi:10.1016/j.bcp.2015.01.016]

  • Masana L, Cabré A, Heras M, Amigó N, Correig X, Martínez-Hervás S, Real JT, Ascaso JF, Quesada H, Julve J, Palomer FX, Vazquez M, Girona J, Plana N and Blanco-Vaca F.

    Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients.

    Atherosclerosis . 238(2): 213-219. Nº de cites: 20

    [doi:10.1016/j.atherosclerosis.2014.12.006]